4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000122
Director sold 10,838 shares at an average $1,158.17 ($12,552,285)
- Director acquired 10,838 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
POON CHRISTINE A · Director
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-08-15 | Exercise or conversion : show line 1 in the form | +10,838 | $413.33 | $4,479,671 | 13,010 | D |
| 2024-08-15 | Sale : show line 2 in the form | −1,012 | $1,155.72 | $1,169,589 | 11,998 | D |
| 2024-08-15 | Sale : show line 3 in the form | −2,368 | $1,156.30 | $2,738,118 | 9,630 | D |
| 2024-08-15 | Sale : show line 4 in the form | −1,560 | $1,157.33 | $1,805,435 | 8,070 | D |
| 2024-08-15 | Sale : show line 5 in the form | −212 | $1,158.02 | $245,500 | 7,858 | D |
| 2024-08-15 | Sale : show line 6 in the form | −5,352 | $1,159.56 | $6,205,965 | 2,506 | D |
| 2024-08-15 | Sale : show line 7 in the form | −234 | $1,160.45 | $271,545 | 2,272 | D |
| 2024-08-15 | Sale : show line 8 in the form | −100 | $1,161.32 | $116,132 | 2,172 | D |
| Open-market sales · 10,838 sh · avg $1,158.17 · $12,552,285 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-08-15 | Exercise or conversion : show line 9 in the form Non-Qualified Stock Option (right to buy) | −10,838 | 0 | D |
Loading xslF345X05/edgardoc.xml…